RTI-336

RTI-336, also known as RTI-4229-336 or LS-193,309 is a potent and selective dopamine reuptake inhibitor that was initially developed by the Research Triangle Institute, now known as RTI International.
Wikipedia contributors, "RTI-336", Wikipedia, revision 1330461867, retrieved 20 November 2026, source, CC BY-SA 4.0.